Sat.Apr 22, 2023 - Fri.Apr 28, 2023

Remove privacy-policy
article thumbnail

Editas grabs orphan drug status for sickle cell disease CRISPR therapy

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy

105
105
article thumbnail

Orbital raises $270m investment for advancement of RNA medicines

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MiNA and BioMarin partner to speed development of RNAa therapies

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy

52
article thumbnail

Forge receives QP declaration to manufacture AAV gene therapies in Europe

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy

52
article thumbnail

NICE recommends Kite’s CAR-T therapies to treat blood cancer

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy

59
article thumbnail

Bristol Myers Squibb to take over US plant for cell therapy production   

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy

52
article thumbnail

EMA’s CHMP recommends approval for Roche’s R/R DLBCL therapy

Pharmaceutical Technology

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy